Good morning :)
$
₹
A

Apnimed, Inc. Common Stock

APMD

NASDAQ
A

Apnimed, Inc. Common Stock

APMD

NASDAQ
$27.116.06% (+1.55)
$
₹
$27.116.06% (+1.55)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Biotechnology

Small Cap

With a market cap of $1.1B the stock is ranked 2710

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

4.46
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

4.40
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$5.72
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

142.1%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Peers

Peers

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here

Financials

Financials

Income

Balance Sheet

Cash Flow

3.1
-28.6
17.1
-69.4
84.8
70.3
12
125.9
Q1 2025
Q2 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2025Q2 2025Q1 2026Q2 2026
Total Revenue3.1317.1184.8112.08
Net Income-28.64-69.4770.37125.93
Net Profit Margin-914.91%-406.04%82.97%1042.50%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Apnimed, Inc. Common Stock (APMD) share price today is $27.11 as of September 17, 2026 at 1:30 AM IST. The stock touched a day high of $27.60 and a day low of $25.29.

  2. Apnimed, Inc. Common Stock stock trades on NASDAQ under the ticker symbol APMD.

  3. Apnimed, Inc. Common Stock's market capitalization is $1.06B as of September 17, 2026 at 1:30 AM IST.

  4. Apnimed, Inc. Common Stock's price-to-earnings (P/E) ratio is 4.46 as of September 16, 2026.

  5. Apnimed, Inc. Common Stock's price-to-book (P/B) ratio is 4.40 as of September 16, 2026.

  6. Yes, You can buy Apnimed, Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Apnimed, Inc. Common Stock shares in three steps: 1. Search Apnimed, Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Apnimed, Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Apnimed, Inc. Common Stock (APMD) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.3688 shares at the current price of $27.11.

Loading...